Sphera Funds Management
Latest statistics and disclosures from Sphera Funds Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, BIIB, MLYS, SNDX, NVMI, and represent 19.29% of Sphera Funds Management's stock portfolio.
- Added to shares of these 10 stocks: COGT (+$9.9M), BMRN (+$8.7M), XBI (+$8.5M), MLYS (+$8.3M), SNDX (+$7.9M), SRRK (+$7.0M), RARE (+$6.9M), BCRX (+$6.5M), WVE (+$6.1M), VOR (+$5.4M).
- Started 24 new stock positions in TARA, BCRX, BMRN, XBI, TNGX, BIOA, STTK, MREO, KOD, TRDA. SRRK, EVMN, DTIL, PALI, PMN, CTNM, ASND, VOR, TENX, NRIX, ZIM, MDGL, PRLD, TNYA.
- Reduced shares in these 10 stocks: TSEM (-$22M), PRAX (-$20M), CDTX (-$17M), MRUS (-$14M), QQQ (-$14M), GPCR (-$13M), TEVA (-$12M), NICE (-$12M), FBRX (-$7.9M), QURE (-$5.8M).
- Sold out of its positions in AMZN, ARWR, BCAX, CEVA, CMMB, CDTX, DSGN, ETNB, ENGN, META.
- Sphera Funds Management was a net seller of stock by $-65M.
- Sphera Funds Management has $517M in assets under management (AUM), dropping by 9.12%.
- Central Index Key (CIK): 0001496201
Tip: Access up to 7 years of quarterly data
Positions held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 98 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.8 | $35M | -25% | 1.1M | 31.21 |
|
| Biogen Idec (BIIB) | 3.2 | $17M | +14% | 95k | 175.99 |
|
| Mineralys Therapeutics (MLYS) | 3.1 | $16M | +104% | 449k | 36.29 |
|
| Syndax Pharmaceuticals (SNDX) | 3.1 | $16M | +96% | 763k | 21.01 |
|
| NOVA MEASURING Instruments L (NVMI) | 3.0 | $16M | +8% | 48k | 328.39 |
|
| Ultragenyx Pharmaceutical (RARE) | 2.9 | $15M | +84% | 651k | 23.00 |
|
| Tower Semiconductor Shs New (TSEM) | 2.8 | $14M | -60% | 123k | 117.42 |
|
| Cogent Biosciences (COGT) | 2.6 | $13M | +284% | 379k | 35.52 |
|
| Astrazeneca Sponsored Adr | 2.4 | $12M | 135k | 91.93 |
|
|
| Praxis Precision Medicines I Com New Call Option (PRAX) | 2.3 | $12M | -62% | 40k | 294.74 |
|
| Sanofi Sa Sponsored Adr (SNY) | 2.2 | $12M | +9% | 240k | 48.46 |
|
| Eli Lilly & Co. (LLY) | 1.9 | $9.7M | -9% | 9.0k | 1074.68 |
|
| Amicus Therapeutics (FOLD) | 1.8 | $9.4M | -33% | 658k | 14.24 |
|
| Immatics SHS (IMTX) | 1.7 | $9.0M | +47% | 861k | 10.50 |
|
| BioMarin Pharmaceutical (BMRN) | 1.7 | $8.7M | NEW | 147k | 59.43 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 1.6 | $8.5M | NEW | 70k | 121.93 |
|
| Bridgebio Pharma (BBIO) | 1.6 | $8.2M | -36% | 108k | 76.49 |
|
| Oric Pharmaceuticals (ORIC) | 1.6 | $8.2M | +132% | 1.0M | 8.18 |
|
| Dyne Therapeutics (DYN) | 1.5 | $7.7M | -7% | 393k | 19.56 |
|
| Trevi Therapeutics (TRVI) | 1.4 | $7.5M | -22% | 599k | 12.52 |
|
| Johnson & Johnson (JNJ) | 1.4 | $7.4M | -12% | 36k | 206.95 |
|
| Savara (SVRA) | 1.4 | $7.1M | -12% | 1.2M | 6.03 |
|
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $7.0M | NEW | 158k | 44.05 |
|
| Wave Life Sciences SHS (WVE) | 1.3 | $6.9M | +716% | 408k | 17.00 |
|
| Cybin Com New (HELP) | 1.3 | $6.8M | +122% | 826k | 8.18 |
|
| Annexon (ANNX) | 1.3 | $6.6M | -26% | 1.3M | 5.02 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $6.5M | NEW | 838k | 7.80 |
|
| Celldex Therapeutics Com New (CLDX) | 1.3 | $6.5M | +15% | 240k | 27.16 |
|
| Soleno Therapeutics (SLNO) | 1.2 | $6.3M | +227% | 136k | 46.30 |
|
| Apellis Pharmaceuticals (APLS) | 1.2 | $6.3M | +294% | 251k | 25.12 |
|
| Nice Sponsored Adr Call Option (NICE) | 1.2 | $6.3M | -64% | 56k | 113.04 |
|
| GSK Sponsored Adr (GSK) | 1.2 | $6.0M | 122k | 49.04 |
|
|
| 4068594 Enphase Energy (ENPH) | 1.2 | $6.0M | +598% | 187k | 32.05 |
|
| Novo-nordisk A S Adr (NVO) | 1.1 | $5.9M | +9% | 116k | 50.88 |
|
| Cytokinetics Com New (CYTK) | 1.1 | $5.8M | -43% | 92k | 63.54 |
|
| Abbvie (ABBV) | 1.1 | $5.8M | 25k | 228.49 |
|
|
| Solaredge Technologies (SEDG) | 1.1 | $5.7M | +39% | 197k | 28.85 |
|
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $5.7M | +42% | 212k | 26.71 |
|
| Vor Biopharma Com New (VOR) | 1.0 | $5.4M | NEW | 410k | 13.08 |
|
| Merck & Co (MRK) | 1.0 | $5.1M | 49k | 105.26 |
|
|
| Novartis Sponsored Adr (NVS) | 1.0 | $5.1M | 37k | 137.87 |
|
|
| Forte Biosciences Com New (FBRX) | 1.0 | $5.1M | -60% | 186k | 27.27 |
|
| Kodiak Sciences (KOD) | 0.9 | $4.9M | NEW | 176k | 27.96 |
|
| Tango Therapeutics (TNGX) | 0.9 | $4.8M | NEW | 545k | 8.86 |
|
| Solaredge Technologies Note 2.250% 7/0 | 0.9 | $4.7M | 4.0M | 1.17 |
|
|
| Astria Therapeutics | 0.9 | $4.7M | +41% | 356k | 13.09 |
|
| Mediwound Shs New (MDWD) | 0.8 | $4.3M | +24% | 230k | 18.46 |
|
| Camtek Ord (CAMT) | 0.8 | $4.2M | +35% | 40k | 106.34 |
|
| Revolution Medicines (RVMD) | 0.8 | $4.2M | -12% | 53k | 79.65 |
|
| Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT) | 0.8 | $4.1M | 47k | 87.16 |
|
|
| Advanced Micro Devices (AMD) | 0.7 | $3.9M | +16% | 18k | 214.16 |
|
| Eliem Therapeutics (CLYM) | 0.7 | $3.7M | +114% | 932k | 4.00 |
|
| Alpha Cognition Com New (ACOG) | 0.7 | $3.7M | +67% | 568k | 6.50 |
|
| Enliven Therapeutics (ELVN) | 0.7 | $3.5M | +35% | 227k | 15.40 |
|
| Protara Therapeutics Com Stk (TARA) | 0.7 | $3.5M | NEW | 650k | 5.33 |
|
| Broadcom (AVGO) | 0.7 | $3.4M | +48% | 9.8k | 346.10 |
|
| Eledon Pharmaceuticals (ELDN) | 0.6 | $3.2M | +44% | 2.1M | 1.51 |
|
| Bioage Labs (BIOA) | 0.6 | $3.2M | NEW | 243k | 13.23 |
|
| Corvus Pharmaceuticals (CRVS) | 0.6 | $3.1M | 408k | 7.70 |
|
|
| Elbit Sys Ord (ESLT) | 0.6 | $3.1M | -20% | 5.3k | 577.71 |
|
| Kura Oncology (KURA) | 0.6 | $3.1M | +20% | 296k | 10.39 |
|
| Maze Therapeatics (MAZE) | 0.6 | $3.0M | -53% | 72k | 41.43 |
|
| Zim Integrated Shipping Serv SHS (ZIM) | 0.6 | $2.9M | NEW | 136k | 21.23 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $2.9M | -81% | 41k | 69.55 |
|
| Evommune Com Shs (EVMN) | 0.5 | $2.8M | NEW | 166k | 17.12 |
|
| Verastem Com New (VSTM) | 0.5 | $2.7M | +338% | 344k | 7.72 |
|
| Amgen (AMGN) | 0.5 | $2.5M | -21% | 7.5k | 327.31 |
|
| Nurix Therapeutics (NRIX) | 0.5 | $2.4M | NEW | 124k | 18.97 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.5 | $2.3M | NEW | 11k | 213.24 |
|
| Tenax Therapeutics Com New (TENX) | 0.4 | $2.3M | NEW | 190k | 12.19 |
|
| Janux Therapeutics (JANX) | 0.4 | $2.2M | +83% | 158k | 13.80 |
|
| Pfizer (PFE) | 0.4 | $2.1M | 86k | 24.90 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.4 | $2.0M | -9% | 368k | 5.50 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.4 | $2.0M | NEW | 174k | 11.43 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $1.9M | NEW | 3.3k | 582.34 |
|
| Pharvaris N V (PHVS) | 0.3 | $1.8M | -46% | 64k | 27.75 |
|
| Varonis Sys (VRNS) | 0.3 | $1.7M | -28% | 53k | 32.80 |
|
| Precision Biosciences Com New (DTIL) | 0.3 | $1.6M | NEW | 396k | 4.16 |
|
| Ventyx Biosciences (VTYX) | 0.3 | $1.6M | -59% | 180k | 9.03 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.3 | $1.5M | +40% | 30k | 49.65 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.3 | $1.4M | -17% | 145k | 9.32 |
|
| Voyager Therapeutics (VYGR) | 0.3 | $1.3M | +70% | 340k | 3.93 |
|
| Entrada Therapeutics (TRDA) | 0.2 | $1.1M | NEW | 111k | 10.28 |
|
| Tenaya Therapeutics (TNYA) | 0.2 | $1.1M | NEW | 1.5M | 0.71 |
|
| Perspective Therapeutics Com New (CATX) | 0.2 | $962k | -31% | 350k | 2.75 |
|
| Bristol Myers Squibb (BMY) | 0.2 | $944k | 18k | 53.94 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.2 | $888k | -22% | 485k | 1.83 |
|
| Pepgen (PEPG) | 0.2 | $791k | -29% | 122k | 6.51 |
|
| Shattuck Labs (STTK) | 0.1 | $713k | NEW | 195k | 3.65 |
|
| Palisade Bio (PALI) | 0.1 | $433k | NEW | 184k | 2.35 |
|
| Werewolf Therapeutics (HOWL) | 0.1 | $397k | 627k | 0.63 |
|
|
| Skye Bioscience Com New (SKYE) | 0.1 | $359k | 479k | 0.75 |
|
|
| Prelude Therapeutics (PRLD) | 0.1 | $356k | NEW | 123k | 2.90 |
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $230k | 270k | 0.85 |
|
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.0 | $175k | 61k | 2.90 |
|
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.0 | $106k | NEW | 255k | 0.42 |
|
| Promis Neurosciences Com Shs (PMN) | 0.0 | $81k | NEW | 12k | 6.83 |
|
| Applied Therapeutics | 0.0 | $5.0k | 50k | 0.10 |
|
Past Filings by Sphera Funds Management
SEC 13F filings are viewable for Sphera Funds Management going back to 2013
- Sphera Funds Management 2025 Q4 filed Feb. 17, 2026
- Sphera Funds Management 2025 Q3 filed Nov. 14, 2025
- Sphera Funds Management 2025 Q2 filed Aug. 14, 2025
- Sphera Funds Management 2025 Q1 filed May 15, 2025
- Sphera Funds Management 2024 Q4 filed Feb. 14, 2025
- Sphera Funds Management 2024 Q3 filed Nov. 14, 2024
- Sphera Funds Management 2024 Q2 filed Aug. 14, 2024
- Sphera Funds Management 2024 Q1 filed May 15, 2024
- Sphera Funds Management 2023 Q4 restated filed Feb. 15, 2024
- Sphera Funds Management 2023 Q4 filed Feb. 14, 2024
- Sphera Funds Management 2023 Q3 filed Nov. 14, 2023
- Sphera Funds Management 2023 Q2 filed Aug. 14, 2023
- Sphera Funds Management 2023 Q1 filed May 15, 2023
- Sphera Funds Management 2022 Q4 filed Feb. 14, 2023
- Sphera Funds Management 2022 Q3 filed Nov. 14, 2022
- Sphera Funds Management 2022 Q2 filed Aug. 15, 2022